Classification
- Anatomical main groupLAntineoplastic and immunomodulating agents
- Therapeutic subgroupL01Antineoplastic agents
- Pharmacological subgroupL01F
- Chemical subgroupL01FF
- Chemical substanceL01FF10Retifanlimab
Where it is registered
Each register with its number of medicines and a few of them.
European Union
EMA · 2 medicines
Canada
Health Canada · 1 medicine
Spain
AEMPS · 1 medicine
Croatia



